IM-810

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameIM-810

Drug Alias NameTCR mimic antibody targeting p53R175H:HLA-A2 complex (Imuno Therapeutics)anti-CD3/anti-p53R175H:HLA-A2 bispecific T-cell engager ( Imuno Therapeutics)IM-810

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionCD3 T-cell engagersTumor protein p53 modulators

TargetsT cell surface glycoprotein CD3Tumor protein p53

Therapy Area/IndicationsPancreatic NeoplasmsColonic NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsColonic NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A